Mork Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-18,504
| Closed | -$545K | – | 128 |
|
|
2022
Q3 | $545K | Hold |
18,504
| – | – | 0.54% | 95 |
|
|
2022
Q2 | $1.01M | Hold |
18,504
| – | – | 0.92% | 45 |
|
|
2022
Q1 | $1.01M | Sell |
18,504
-2,696
| -13% | -$147K | 0.91% | 57 |
|
|
2021
Q4 | $1.17M | Hold |
21,200
| – | – | 0.79% | 53 |
|
|
2021
Q3 | $1.01M | Hold |
21,200
| – | – | 0.86% | 65 |
|
|
2021
Q2 | $1.06M | Hold |
21,200
| – | – | 0.76% | 75 |
|
|
2021
Q1 | $946K | Buy |
+21,200
| New | +$946K | 0.72% | 83 |
|
|
2017
Q4 | – | Sell |
-17,760
| Closed | -$901K | – | 127 |
|
|
2017
Q3 | $901K | Hold |
17,760
| – | – | 0.73% | 67 |
|
|
2017
Q2 | $957K | Hold |
17,760
| – | – | 0.82% | 54 |
|
|
2017
Q1 | $936K | Hold |
17,760
| – | – | 0.83% | 50 |
|
|
2016
Q4 | $855K | Buy |
+17,760
| New | +$855K | 0.6% | 78 |
|